MedTrace Logo

A Clinical Comparison of Three Contact Lens Care Systems and Their Effect on Contact Lenses

NCT00982046 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2016-11-16

No results posted yet for this study

Summary

The purpose of this study was to evaluate the clinical performance of three differing contact lens care solutions when used in conjunction with three contact lenses.

Conditions

  • Contact Lenses

Interventions

DEVICE

Opti-Free RepleniSH multi-purpose disinfecting solution

Contact lens solution CE-marked for intended use.

DEVICE

ReNu MultiPlus multi-purpose solution

Contact lens solution CE-marked for intended use.

DEVICE

Clear Care cleaning and disinfecting system

Contact lens care system CE-marked for intended use.

DEVICE

Senofilcon A contact lens (ACUVUE OASYS)

Silicone hydrogel contact lens worn for two weeks on a daily wear basis and cleaned nightly with one of three contact lens care solutions. The order of solutions was randomized, and a fresh pair of lenses was dispensed with each solution.

DEVICE

Lotrafilcon B contact lens (AIR OPTIX AQUA)

Silicone hydrogel contact lens worn for two weeks on a daily wear basis and cleaned nightly with one of three contact lens care solutions. The order of solutions was randomized, and a fresh pair of lenses was dispensed with each solution.

DEVICE

Comfilcon A contact lens (Biofinity)

Silicone hydrogel contact lens worn for two weeks on a daily wear basis and cleaned nightly with one of three contact lens care solutions. The order of solutions was randomized, and a fresh pair of lenses was dispensed with each solution.

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2010-05-31
Completion
2010-05-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00982046 on ClinicalTrials.gov